A more recently recognized contributor to ED is the endothelial-to-mesenchymal transition, a process by which endothelial cells acquire mesenchymal characteristics, losing markers such as VE-cadherin and gaining fibrotic and migratory phenotypes (4737)
Some clinicians recommend temporary appetite-support supplementssuch as glucomannan or psylliumto enhance satiety during weeks when medication levels are dropping
Drugs like semaglutide (Wegovy) and tirzepatide (Zepbound) have shown to improve efficacy compared to older weight-loss medications, with patients losing up to 20% of their body weight
Atherosclerosis 352, 8895
However, like with any medication, its important to consult your doctor before taking Semaglutide
Programs commonly frame this treatment around recovery, sleep, and metabolic support rather than as a one-size-fits-all protocol